Intelligence / Healthtech / PMA Approvals / Medtronic Minimed, INC.
Approvalsdevice change approved (PMA)29 Sept 2026
Medtronic Minimed, INC.
29 Sept 2026: Device change approved (PMA) · MiniMed 780G System. Recorded in the openFDA device PMA data.
- Decided
- 29 Sept 2026
- Device
- MiniMed 780G System
- Specialty
- Clinical Chemistry
- Type
- Supplement (Normal 180 Day Track No User Fee)
- Reason
- Postapproval Study Protocol
- Reference
- P160017 S140
- Location
- Northridge, CA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Medtronic Minimed, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Medtronic Minimed, INC. in our registers.
28 OctMedtronic Minimed, INC.Class II recall · HealthtechQuality28 OctMedtronic Minimed, INC.Class II recall · HealthtechQuality14 OctMedtronic Minimed, INC.Class II recall · HealthtechQuality26 AugMedtronic Minimed, INC.Class II recall · HealthtechQuality26 AugMedtronic Minimed, INC.Class II recall · HealthtechQuality26 AugMedtronic Minimed, INC.Class II recall · HealthtechQuality
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.